Researcher
Hans Prenen
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention, Cancer therapy
- Disciplines (KU Leuven):Morphological sciences, Oncology
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Oct 2020 → Today - Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From12 Jul 2017 → 30 Apr 2018 - Clinical Digestive Oncology (Division)
Member
From1 Jan 2012 → 23 Jul 2017 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2009 → 31 Dec 2011
Projects
1 - 2 of 2
- Development of an image-based multiparametric drug response signature to predict clinical therapy response in cancer patients from ex vivo tumoroid screenings.From1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- Reinvigorating the antitumor immunity in human breastand cervical cancer with an innovative RANK(L) targeted combination strategy.From1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 10 of 71
- GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level(2022)
Authors: Julia Schröder, Laura Chegwidden, Carlo Maj, Jan Gehlen, Jan Speller, Anne C. Böhmer, Oleg Borisov, Timo Hess, Nicole Kreuser, Marino Venerito, et al.
Pages: 1 - 12 - Sotorasib for previously treated colorectal cancers with $KRAS^{G12C}$ mutation (CodeBreaK100)(2022)
Authors: Marwan G. Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N. Munster, John C. Krauss, Gerald S. Falchook, Sae-Won Han, Volker Heinemann, Kei Muro, et al.
Pages: 115 - 124 - Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer(2022)
Authors: Yana Debie, Jonas Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Maria Goossens, et al.
Pages: 1 - 12 - The nitrogen mustards(2022)
Authors: Martin S. Highley, Bart Landuyt, Hans Prenen, Peter G. Harper, Ernst A. De Bruijn, Michael Gottesman
Pages: 552 - 599 - Targeting hedgehog signaling in pancreatic ductal adenocarcinoma(2022)
Authors: Delphine Quatannens, Yannick Verhoeven, Peter Van Dam, Filip Lardon, Hans Prenen, Marc Peeters, Evelien Smits, Jonas Van Audenaerde
- Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia(2022)
Authors: Elisabeth Wyart, Myriam Y. Hsu, Roberta Sartori, Erica Mina, Valentina Rausch, Elisa S. Pierobon, Mariarosa Mezzanotte, Camilla Pezzini, Laure B. Bindels, Andrea Lauria, et al.
- eQTL set–based association analysis identifies novel susceptibility loci for Barrett esophagus and esophageal adenocarcinoma(2022)
Authors: Xiaoyu Wang, Puya Gharahkhani, David M. Levine, Rebecca C. Fitzgerald, Ines Gockel, Douglas A. Corley, Harvey A. Risch, Leslie Bernstein, Wong-Ho Chow, Lynn Onstad, et al.
Pages: 1735 - 1745 - Excellent response to MEK inhibition in an AGK-BRAF gene fusion driven carcinoma(2022)
Authors: Andreas Domen, Carl Van Paesschen, Suzan Lambin, Patrick Pauwels, Marika Rasschaert, E.V.A. Segelov, Marc Peeters, Hans Prenen
Pages: 373 - 379 - Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma(2022)
Authors: Delphine Vervloet, Dieter Berwouts, Roel Beckers, Hans Prenen, Marc Peeters, Félix Gremonprez, Lieselot Croes, Christof Vulsteke
Pages: 1 - 7 - Prognostic implications of cellular senescence in resected non-small cell lung cancer(2022)
Authors: Andreas Domen, Christophe Deben, Ines De Pauw, Christophe Hermans, Hilde Lambrechts, Jasper Verswyvel, Vasiliki Siozopoulou, Patrick Pauwels, Marco Demaria, Mick van de Wiel, et al.
Pages: 1526 - 1539